“Exerkine” is an umbrella term for molecules released or changed in response to exercise. “Myokine” usually refers to a signal produced by skeletal muscle, although definitions and measurement methods vary. The field is interesting because exercise affects immune, metabolic, vascular, neural, and musculoskeletal systems. It is also easy to overstate: a short-lived change in blood concentration is not proof of a long-term benefit.
What a biomarker study can show
Researchers may measure a molecule before and after one session, across a training programme, or in muscle tissue. Those designs answer different questions. A transient rise after a hard session can describe an acute response; it cannot establish that the molecule caused hypertrophy, improved health, or should be artificially increased.
An acute-resistance-exercise meta-analysis found increases in several immunoregulatory myokines, including IL-6, IL-1ra, TNF-α, and IL-15. The results varied by molecule and time point, and the review did not show that a particular response predicts muscle growth (Wang et al.). A broader 2024 review found that aerobic and resistance training both changed myokine measures, with the size and timing of the change depending on the molecule and protocol (Belviranli et al.).
IL-6 is not simply “good” or “bad”
IL-6 can rise during exercise and also appears in chronic inflammatory states. The context, source, time course, and accompanying signals matter. It is not scientifically sound to call every acute IL-6 increase either muscle-building or harmful, and it is not a useful reason to chase a particular amount of soreness or training volume.
Irisin, BDNF, IGF-1, and FGF21
These molecules are often presented as a list of exercise “hormones,” but the evidence is not equally mature for each one. Assays, tissues, time points, exercise modes, and participant health differ. Some findings are mechanistic, animal, or observational. A circulating value may not reflect what is happening inside a specific muscle or brain region.
Use these signals to understand research questions, not to diagnose recovery or select an exercise because it supposedly maximizes one molecule. If a product claims to “boost exerkines,” ask whether it has a controlled human trial showing a meaningful outcome rather than only a biomarker change.
Myostatin and the idea of an exercise pill
Myostatin participates in the regulation of muscle growth, but a pathway target is not a safe supplement. Reviews of myostatin inhibition describe major translation and functional-outcome challenges, and exercise-related biomarker changes do not prove that a consumer compound can reproduce them (Sinha-Hikim et al.).
The idea of isolating exercise signals into a medicine is a legitimate research direction. Animal results and cell experiments can help generate hypotheses, but they are not evidence that an injection, “myokine stack,” or peptide is an appropriate training aid.
What to do in practice
The most reliable way to influence the overall exercise-response network is still ordinary training that you can repeat:
- progress resistance exercise at a tolerable dose;
- include aerobic work when it supports health and the goal;
- eat enough to support the training demand;
- sleep and recover adequately;
- adjust the programme from performance and symptoms, not a speculative blood marker.
There is no validated exerkine dashboard that can tell a healthy lifter how many sets to perform, whether to train fasted, or whether recovery is complete. A wearable or blood test can add data, but more data is not the same as more causal insight.
Bottom line
Exercise changes a network of signals between muscle and other tissues. The most reproducible human evidence currently supports acute and training-related biomarker changes, not a single “master” molecule or a guaranteed hypertrophy pathway. Keep the mechanistic story interesting, but let measured performance, health, and consistency drive the programme.
Related reading
- Myostatin and the limits of muscle-growth claims
- Muscle protein synthesis and hypertrophy
- Training hard enough without guessing
Limits of the evidence
Exerkine research combines acute human trials, chronic interventions, observational work, animal models, and different assays. Biomarker changes do not establish causation, a clinical benefit, or a dose-response rule for resistance training.
Sources
- Immunoregulatory myokines after acute resistance exercise. Systematic review and meta-analysis of acute responses.
- Exercise training mode effects on myokine expression. 2024 systematic review and meta-analysis.
- Short-lived exercise-induced exerkines and inflammation. 2025 review; heterogeneity and clinical endpoints remain limitations.
- Therapeutic applications and challenges in myostatin inhibition. Translation and safety context.
APPLY IT IN THE GYM
Build the body people notice.
Surpass keeps working sets, recent performance, targets, and rest timing together on iPhone.
Start free on iPhone